Saol Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Saol Therapeutics's estimated annual revenue is currently $11.3M per year.
- Saol Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Saol Therapeutics has 56 Employees.
- Saol Therapeutics grew their employee count by 4% last year.
Saol Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Regulatory | Reveal Email/Phone |
2 | SVP, Strategy | Reveal Email/Phone |
3 | VP Finance | Reveal Email/Phone |
4 | VP, Operations & Compliance | Reveal Email/Phone |
5 | QA and Regulatory Affairs Director | Reveal Email/Phone |
6 | Senior Director, Drug Product Development | Reveal Email/Phone |
7 | Medical Director | Reveal Email/Phone |
8 | Senior Director Strategic Marketing | Reveal Email/Phone |
9 | Senior Director Strategic Marketing | Reveal Email/Phone |
10 | General Manager | Reveal Email/Phone |
Saol Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $29.7M | 148 | 8% | N/A | N/A |
#2 | $10.5M | 52 | -2% | N/A | N/A |
#3 | $11.3M | 56 | 4% | N/A | N/A |
#4 | $29.1M | 145 | 21% | N/A | N/A |
#5 | $6.8M | 34 | -6% | N/A | N/A |
#6 | $18.1M | 90 | -35% | N/A | N/A |
#7 | $48.2M | 240 | 37% | N/A | N/A |
#8 | $1.2M | 12 | 140% | $50M | N/A |
#9 | $12.5M | 62 | -9% | N/A | N/A |
#10 | $10.1M | 50 | -2% | N/A | N/A |
What Is Saol Therapeutics?
Saol Therapeutics (pronounced ?Sail??) is a privately held specialty pharmaceutical company focused on providing therapies to patients with rare diseases. The company has a strategic emphasis on the neurology therapeutic area. For more information, please visit our website: www.saolrx.com.
keywords:N/AN/A
Total Funding
56
Number of Employees
$11.3M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Saol Therapeutics News
2022-04-20 - Amneal Scores Second US Biosimilar Approval With Avastin ...
Amneal says an $83.5m deal to acquire Saol Therapeutics' baclofen franchise will also bring the firm an experienced institutional...
2022-03-22 - Saol Therapeutics and GeneDx, Inc. Collaborate to Detect ...
Saol is focused on clinical development activity in rare diseases, with a focus on mitochondrial disorders, as well as central nervous system...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.9M | 57 | 19% | N/A |
#2 | $17.2M | 58 | 16% | N/A |
#3 | $15.7M | 60 | 3% | N/A |
#4 | $15.7M | 60 | 20% | N/A |
#5 | $11.1M | 61 | 5% | N/A |
